FDA 483 - Nova Southeastern University IRB #1 - August 17, 2023
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Nova Southeastern University IRB #1 in Davie, FL, revealed three observations concerning its Institutional Review Board (IRB) operations. The firm failed to adhere to its written procedures for initial research review and omitted critical information from informed consent documents, specifically regarding alternate treatment options and the potential for FDA record inspection. These findings highlight deficiencies in the IRB's compliance with established protocols and informed consent requirements.
ID · a8820506-5a45-4631-9770-46c54ebf0468